動物雙歧桿菌乳酸亞種 BB-12 Bifidobacterium animalis subsp. lactis BB-12 × 普通感冒
結論：證據支持但有警示
最高品質的 strain-exact 證據（2018 系統性回顧 + Hojsak 2016 RCT，n=343）在日托兒童族群顯示 BB-12 對呼吸道感染病程與缺席天數均無顯著效果；僅有兩項小型成人 RCT（Meng 2016 n=30、Smith 2013 與 LGG 共用配方）顯示部分免疫指標或症狀生活品質改善，樣本量小且 Smith 試驗的 BB-12 效果無法與 LGG 分離。
C 🟠 C 薄弱證據 附警語發布 🚨 high — heavy affiliate marketing in TW community
最高品質的 strain-exact 證據（2018 系統性回顧 + Hojsak 2016 RCT，n=343）在日托兒童族群顯示 BB-12 對呼吸道感染病程與缺席天數均無顯著效果；僅有兩項小型成人 RCT（Meng 2016 n=30、Smith 2013 與 LGG 共用配方）顯示部分免疫指標或症狀生活品質改善，樣本量小且 Smith 試驗的 BB-12 效果無法與 LGG 分離。
L5 系列權威衛教（Mayo、Cleveland、Harvard、NCCIH）幾乎全為「probiotics 類別」泛論，無 BB-12 株別專屬建言，存在明顯 strain-specificity 缺口，不可上推為 BB-12 強證據。
綜合 strain-exact 結果偏 null、權威來源僅給弱通用性支持，給予 C（弱／混合，且以兒童族群之 null 結果為主）。
⚖️
評分透明度
所有分數由 7 層證據引擎計算，過程公開可查原始分數 0.48
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
C · 附警語發布
信心度
58%
證據方向分歧
證據層級
E3
單篇高品質統合分析
▸查看完整決策路徑（audit trail）
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.481
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 無高階證據可裁決
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
Probiotics for respiratory tract infections in children attending day care centers (systematic review)
— 詳細結論請見 PubMed 原文
前往 PubMed
Bifidobacterium animalis subsp. lactis in prevention of common infections in healthy children attending day care centers (Hojsak et al.)
— 詳細結論請見 PubMed 原文
前往 PubMed
Consumption of Bifidobacterium animalis subsp. lactis BB-12 impacts upper respiratory tract infection and the function of NK and T cells in healthy adults (Meng et al.)
— 詳細結論請見 PubMed 原文
前往 PubMed
Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood (Taipale et al.)
— 詳細結論請見 PubMed 原文
前往 PubMed
Effect of Lactobacillus rhamnosus LGG and Bifidobacterium animalis ssp. lactis BB-12 on health-related quality of life in college students affected by upper respiratory infections (Smith et al.)
— 詳細結論請見 PubMed 原文
前往 PubMed
L4a US FDA
支持
GRN 856 - Bifidobacterium animalis subsp. lactis strain BB-12; Status: FDA closure with no objections; No-Objection Letter Date: December 9, 2019; Intended Use: 'For use as an ingredient in conventional foods for use by the general population, excluding foods subject to regulation by the USDA, at levels intended to provide 5 x 10^11 CFU/serving.' Notifier: Chr. Hansen, Inc. (Milwaukee, WI). 來源↗
L4b EU EFSA
謹慎
Scientific Opinion on the substantiation of health claims related to Bifidobacterium animalis ssp. lactis Bb-12 and immune defence against pathogens (ID 863), decreasing potentially pathogenic gastro-intestinal microorganisms (ID 866), 'natural immune function' (ID 924), reduction of symptoms of inflammatory bowel conditions (ID 1469) and maintenance of normal blood LDL-cholesterol concentratio… 來源↗
L4c UK NHS
謹慎
There's some evidence that probiotics may be helpful in some cases, such as helping to ease some symptoms of irritable bowel syndrome (IBS). But there's little evidence to support many health claims made about them. For example, there's no evidence to suggest that probiotics can help treat eczema. Probiotics are generally classed as food rather than medicine, which means they don't go through t… 來源↗
L4d TW TFDA / 衛福部
中性
— 本適應症無對應資料
L4e WHO
中性
— 本適應症無對應資料
L5a NIH Office of Dietary Supplements
支持
The BB-12 Bifidobacterium animalis subsp. lactis strain is one of the most documented probiotic strains on the market and has been shown to be effective in alleviating symptoms of a low defecation frequency and infant colic, among others. The strain has been granted GRAS (generally recognized as safe) status in the United States, and the species has QPS (qualified presumption of safety) status … 來源↗
L5b Mayo Clinic
支持
Taking probiotics regularly can lower your chances of getting a cold. Probiotics appear to improve the body's immune response, which helps the body be better prepared to fight off certain infections, including the common cold. Beyond prevention, if you do catch a cold, probiotics may help reduce the severity of your symptoms and shorten how long they last. 來源↗
L5c Cleveland Clinic
中性
For example, some people take probiotics to improve their immunity during the cold and flu season. 來源↗
L5d Harvard Health
謹慎
Probiotics may also reduce the number of colds you'll have in a year. 來源↗
L5e Specialty Society (condition-mapped)
謹慎
Probiotics have been tested for their effects against upper respiratory infections (a group that includes the common cold, middle ear infections, sinusitis, and various throat infections). A 2015 evaluation of 12 studies with 3,720 total participants indicated that people taking probiotics may have fewer and shorter upper respiratory infections. However, the quality of the evidence was low beca… 來源↗
PTT · Dcard · Mobile01 彙整自公開論壇討論，非統計抽樣，僅反映社群風向。
廣告 / 業配密度 極高
低中高
📍立場總覽
台灣社群（PTT、Dcard、Mobile01、BabyHome）對 BB-12 菌株與「普通感冒」直接連結的討論非常稀少；少數有提到 BB-12 的內容集中在「妙可適 LGG+BB-12」膠囊／滴劑，主訴為異位性皮膚炎、腸胃保健與寶寶體質調整，並非感冒預防。多數社群討論為通稱「益生菌」而非特定菌株，且痞客邦／部落格類文章多為品牌業配，廣告污染明顯。
💬社群實感
資料不足
破解迷思 社群最常見的 4 個誤解
✓
事實把「益生菌」當成單一產品，忽略菌株不同效果差很多（BB-12 與 LGG 常被混為一談）
✓
事實誤以為吃益生菌可以直接「治感冒」，而非僅可能輔助降低呼吸道感染機率
✓
事實認為菌數越多越有效，忽略菌株證據強度
✓
事實把妙可適（主打異膚／腸胃）誤推給感冒族群
🩹 社群通報的副作用
- 初期脹氣、放屁變多
- 少數人腹瀉或便秘加劇
- 極少回報嚴重不良反應
🏷️ 社群熱議品牌
依論壇被提及頻率，非銷售或品質排序。
- 妙可適 Muco-relax（漢昇生技，LGG+BB-12）
- Culturelle 康萃樂（LGG）
- 樂亦康（Morinaga BB536）
- 養樂多 Yakult（LcS）
- 白蘭氏益生菌
⚠️ 列出僅代表「TW 社群討論度高」，不代表本站推薦或背書。本站不販售任何產品、無導購連結。
- 症狀緩解與支持性照護（休息、補充水分）
- 預防措施（勤洗手等物理防護、流感疫苗）
查看 ClaimReview 結構化資料 (JSON-LD)
{
"@context": "https://schema.org",
"@type": "ClaimReview",
"url": "https://gpt-dict.com/claim/CLM-COND-common-cold-INT-bifidobacterium-animalis-bb-12-001/",
"datePublished": "2026-06-01",
"author": {
"@type": "Organization",
"name": "gpt-dict.com",
"url": "https://gpt-dict.com"
},
"claimReviewed": "動物雙歧桿菌乳酸亞種 BB-12能改善普通感冒",
"inLanguage": "zh-TW",
"itemReviewed": {
"@type": "Claim",
"appearance": []
},
"reviewRating": {
"@type": "Rating",
"ratingValue": 2,
"bestRating": 5,
"worstRating": 1,
"alternateName": "🟠 C 薄弱證據"
}
}